Cargando…
Development of an appropriate simple suspension method for valganciclovir medication
BACKGROUND: Valganciclovir (VGC) is essential for preventing cytomegalovirus infections after transplants in adult and pediatric patients. In pediatric patients, VGC tablets have to be pulverized so that they can be delivered via nasogastric tubes. The “simple suspension method” is usually used to s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339454/ https://www.ncbi.nlm.nih.gov/pubmed/32655872 http://dx.doi.org/10.1186/s40780-020-00172-w |
_version_ | 1783554894919106560 |
---|---|
author | Masaoka, Yasuyuki Kawasaki, Yoichi Kikuoka, Ryo Ogawa, Atsushi Esumi, Satoru Wada, Yudai Ushio, Soichiro Kitamura, Yoshihisa Sendo, Toshiaki |
author_facet | Masaoka, Yasuyuki Kawasaki, Yoichi Kikuoka, Ryo Ogawa, Atsushi Esumi, Satoru Wada, Yudai Ushio, Soichiro Kitamura, Yoshihisa Sendo, Toshiaki |
author_sort | Masaoka, Yasuyuki |
collection | PubMed |
description | BACKGROUND: Valganciclovir (VGC) is essential for preventing cytomegalovirus infections after transplants in adult and pediatric patients. In pediatric patients, VGC tablets have to be pulverized so that they can be delivered via nasogastric tubes. The “simple suspension method” is usually used to suspend tablets in hot water in Japan. However, the optimal suspension conditions and metering methods for preparing VGC suspensions using the simple suspension method are unclear. The purpose of this study was to clarify these issues. METHODS: VGC tablets were suspended in water (initial water temperature: 25 °C or 55 °C) using the simple suspension method. The residual rate of VGC after it had been suspended in hot water was determined using HPLC. In addition, the suspended solution was passed through 6, 8, and 12 Fr. gavage tubes. The VGC concentrations of suspensions produced using different preparation methods were also determined using HPLC. RESULTS: Cracking the surfaces of VGC tablets and suspending them in water at an initial temperature of 55 °C was effective at dissolving the tablets. The VGC concentration of the suspension remained stable for at least 80 min. Furthermore, the VGC concentration remained stable for 48 h during cold dark storage. Cracking the surfaces of VGC tablets could be a more effective metering method than preparing powder from VGC tablets. In addition, little VGC remained in 6, 8, or 12 Fr. gavage tubes after VGC solution was passed through them. CONCLUSION: The amount of VGC should be measured carefully when preparing VGC solutions using the simple suspension method. |
format | Online Article Text |
id | pubmed-7339454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73394542020-07-09 Development of an appropriate simple suspension method for valganciclovir medication Masaoka, Yasuyuki Kawasaki, Yoichi Kikuoka, Ryo Ogawa, Atsushi Esumi, Satoru Wada, Yudai Ushio, Soichiro Kitamura, Yoshihisa Sendo, Toshiaki J Pharm Health Care Sci Research Article BACKGROUND: Valganciclovir (VGC) is essential for preventing cytomegalovirus infections after transplants in adult and pediatric patients. In pediatric patients, VGC tablets have to be pulverized so that they can be delivered via nasogastric tubes. The “simple suspension method” is usually used to suspend tablets in hot water in Japan. However, the optimal suspension conditions and metering methods for preparing VGC suspensions using the simple suspension method are unclear. The purpose of this study was to clarify these issues. METHODS: VGC tablets were suspended in water (initial water temperature: 25 °C or 55 °C) using the simple suspension method. The residual rate of VGC after it had been suspended in hot water was determined using HPLC. In addition, the suspended solution was passed through 6, 8, and 12 Fr. gavage tubes. The VGC concentrations of suspensions produced using different preparation methods were also determined using HPLC. RESULTS: Cracking the surfaces of VGC tablets and suspending them in water at an initial temperature of 55 °C was effective at dissolving the tablets. The VGC concentration of the suspension remained stable for at least 80 min. Furthermore, the VGC concentration remained stable for 48 h during cold dark storage. Cracking the surfaces of VGC tablets could be a more effective metering method than preparing powder from VGC tablets. In addition, little VGC remained in 6, 8, or 12 Fr. gavage tubes after VGC solution was passed through them. CONCLUSION: The amount of VGC should be measured carefully when preparing VGC solutions using the simple suspension method. BioMed Central 2020-07-07 /pmc/articles/PMC7339454/ /pubmed/32655872 http://dx.doi.org/10.1186/s40780-020-00172-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Masaoka, Yasuyuki Kawasaki, Yoichi Kikuoka, Ryo Ogawa, Atsushi Esumi, Satoru Wada, Yudai Ushio, Soichiro Kitamura, Yoshihisa Sendo, Toshiaki Development of an appropriate simple suspension method for valganciclovir medication |
title | Development of an appropriate simple suspension method for valganciclovir medication |
title_full | Development of an appropriate simple suspension method for valganciclovir medication |
title_fullStr | Development of an appropriate simple suspension method for valganciclovir medication |
title_full_unstemmed | Development of an appropriate simple suspension method for valganciclovir medication |
title_short | Development of an appropriate simple suspension method for valganciclovir medication |
title_sort | development of an appropriate simple suspension method for valganciclovir medication |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339454/ https://www.ncbi.nlm.nih.gov/pubmed/32655872 http://dx.doi.org/10.1186/s40780-020-00172-w |
work_keys_str_mv | AT masaokayasuyuki developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT kawasakiyoichi developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT kikuokaryo developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT ogawaatsushi developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT esumisatoru developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT wadayudai developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT ushiosoichiro developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT kitamurayoshihisa developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication AT sendotoshiaki developmentofanappropriatesimplesuspensionmethodforvalganciclovirmedication |